Cite
HARVARD Citation
Hageman, S. et al. (2022). Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectiveness. European journal of preventive cardiology. pp. 635-644. [Online].